Immunocompromised

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial

Not yet recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
  • +4 more
  • Cooperstown, New York
  • +10 more
Dec 11, 2022

Immunocompromised Trial in Mexico, United States (casirivimab+imdevimab, Placebo)

Terminated
  • Immunocompromised
  • Birmingham, Alabama
  • +66 more
Jul 26, 2022

COVID-19 Vaccination and Breakthrough Infections Among Persons

Completed
  • Immunocompromised
  • +5 more
  • BNT162b2 (Tozinameran)
  • New York, New York
    Pfizer Inc.
Jul 1, 2022

Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)

Recruiting
  • Lower Respiratory Tract Infection
  • +3 more
  • Duarte, California
  • +59 more
Jun 3, 2022

Immunocompromised, Hematologic Malignancy, Post Hematopoietic Stem Cell Transplant Trial in Toronto (High Flow Nasal Cannula or

Active, not recruiting
  • Immunocompromised
  • +4 more
  • High Flow Nasal Cannula or Low Flow Nasal Cannula
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Apr 4, 2022

Follow-up of Fungal Pathogens in Immunocompromised Pediatric

Completed
  • Invasive Fungal Disease
  • +3 more
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Jun 13, 2019

    Immunocompromised, Bone Marrow Transplant, Cancer Trial in Cincinnati (Micafungin)

    Terminated
    • Immunocompromised
    • +2 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    May 21, 2018

    Immunocompromised, Transplanted Trial in Hannover (Fluad 1x)

    Completed
    • Immunocompromised
    • Transplanted
    • Fluad 1x
    • Hannover, Germany
      Medical School Hannover
    Apr 13, 2012

    Immunocompromised Trial in Hannover (Focetria (2x H1N1 vaccine with MF59 adjuvants))

    Terminated
    • Immunocompromised
    • Focetria (2x H1N1 vaccine with MF59 adjuvants)
    • Hannover, Germany
      Hannover Medical School
    Apr 13, 2012

    Invasive Pulmonary Aspergillosis by Direct Lung Tissue

    Unknown status
    • Immunocompromised
    • Lung aspiration
    • Taipei, Taiwan
      National Taiwan University Hospital
    Feb 18, 2011